New Key Statistics Module, Z-Score and F-Score
NAS:CAPR Key Ratios
| Market Cap $ M | 914.48 |
| Enterprise Value $ M | 906.38 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 55.94 |
| Price/Sales | 22.56 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 27.00 |
| EPS (TTM) $ | -0.89 |
| Beneish M-Score | -0.71 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 26.00 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -30.21 |
| EV-to-EBITDA | -31.55 |
| PEG | -- |
| Shares Outstanding M | 45.41 |
| Net Margin (%) | -102.93 |
| Operating Margin % | -110.50 |
| Pre-tax Margin (%) | -102.93 |
| Quick Ratio | 1.37 |
| Current Ratio | 1.37 |
| ROA % (ttm) | -60.86 |
| ROE % (ttm) | -261.28 |
| ROIC % (ttm) | -96.33 |
| Dividend Yield % | -- |
| Altman Z-Score | 12.90 |
CAPR Number of Guru Trades
CAPR Volume of Guru Trades
Gurus Latest Trades with NAS:CAPR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CAPR is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Capricor Therapeutics Inc Insider Transactions
No Available Data
News about NAS:CAPR
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers